Overview of the ANVISA SNCM regulations, industry traceability, and serialization standards
Fill out the form below to access the webinar:
Preencha o formulário abaixo para acessar o webinar sobre Serialização e Rastreabilidade.
A apresentação será realizada por Vinicius Bagnarolli – Diretor de Operações LATAM
rfxcel is participating in a webinar presented by the COVID-19 Healthcare Coalition on December 17, 2020. Collectively, the coalition pulled together a distinguished set of speakers, including moderator Kevin Smith of the rfxcel Public Sector Team, and we are looking forward to the depth of knowledge that will be shared during the presentation. I hope that you will be able to join us, as we dive deeper into the issues our healthcare supply chain is facing amidst the COVID-19 pandemic.
This webinar is the 3rd in a series of 3.
Title: Coordinating a National Response to Counterfeit Mitigation
Due to the COVID-19 pandemic, the healthcare industry has seen demand grow 10 to 15 times pre-COVID levels. Suppliers have struggled to keep pace with this demand, and counterfeiters have taken advantage of the situation to sell substandard products to desperate buyers. This webinar will address how industry, healthcare, and government (federal, state, and local) can work together to reduce counterfeits.
Panelists
Note: This 12:00-1:30 p.m. ET webinar is the third in a three-part series. Recordings of all webinars will be available on the rfxcel website following this presentation.
Login information: This webinar does not require pre-registration, please use the join link below.
https://mitre.zoomgov.com/j/1612791398?pwd=SGN6L3VnSWF0ZlRGQ2ZQV3UzbkFVZz09
Wednesday, December 2, 2020 at 12-1:30 pm Eastern
Due to the COVID-19 pandemic, the healthcare industry has seen demand grow 10 to 15 times pre-COVID levels. Suppliers have struggled to keep pace with this demand, and counterfeiters have taken advantage of the situation to sell substandard products to desperate buyers. This webinar will address how procurement leaders and their supply chain partners manage counterfeit risks and identify the tools, resources, and practices that procurement organizations can leverage to make informed buying decisions.
Login information:
Join from a PC, Mac, iPad, iPhone or Android device:
Please click this URL to join. https://mitre.zoomgov.com/s/1602705055?pwd=TVpaNXE5M3BqVFpYbDV3WkJ5L2hEUT09
Passcode: 629454
Or join by phone:
Dial(for higher quality, dial a number based on your current location):
US: +1 669 254 5252 or +1 646 828 7666
Webinar ID: 160 270 5055
International numbers available: https://mitre.zoomgov.com/u/adcaBWlpBw
Access webinar recording here
DSCSA Guidance and FDA explain the latest enforcements and changes in the regulation.
Do you have questions about the enforcement delay of the DSCSA? Not sure what this means for you?
Brian will answer your questions, explain exactly what you have to do to comply, and give insights into the DSCSA as we move into 2021.
Once registered, you will receive a confirmation email. Please note that given the nature of this session, we will rely heavily on your questions and how we can best serve you. Please let us know what you are wondering about by sending your questions to marketing@rfxcel.com or by bringing them with you to the webinar and simply entering them into the chat at any time during the call.
In the meantime, check out rfxcel’s latest blogs on this topic: FDA Delays Enforcement of DSCSA Saleable Returns Requirement and Industry Reaction to Delayed Enforcement of DSCSA Saleable Returns.
Download DSCSA Guide here
About Brian Files:
Brian Files is rfxcel’s DSCSA Strategic Advisor and principal and founder of BBF Consulting, LLC, and an expert on the U.S. and international pharmaceutical and healthcare supply chain compliance. He has an M.B.A. from the University of Michigan and a B.A. from Cornell University.
We are looking forward to the opportunity to speak with you soon!
This webinar ended. Please click here to request the DSCSA Guidance and recording.
An IQPC & rfxcel Webinar
By Mark Davison, rfxcel
THIS WEBINAR ENDED. YOU CAN ACCESS THE RECORDING BELOW.
———
Mark Davison is the Vice President of International Business for rfxcel. He is a leading traceability and digital health expert, specializing in the Internet of Things (IoT), traceability, and blockchain solutions. The author of “Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs”, Mark specializes in global health and big data issues that affect key industries such as pharmaceuticals, food/beverage, and fast-moving consumer goods (FMCG). His expertise lies heavily in serialization, supply chain security, patient safety, and government policy. He resides in the United Kingdom.
—
Please fill out the form below to get access to the webinar recording.
THIS WEBINAR ENDED. YOU CAN ACCESS THE RECORDING BELOW.
———
This webinar will cover the full scope of the serialization requirements in Russia, including all mandatory labeling requirements for 2019 and 2020.
In recent years, the serialization landscape has undergone drastic changes, with a number of new regulations coming into force. This has drastically impacted operations for many pharmaceutical companies.
There are still new changes on the horizon, with one of the most complex regulations quickly approaching from Russia.
By 2020, all pharmaceutical companies distributing in Russia must have complete unit and batch level traceability.
Considering the length of time needed to implement changes, if companies want to be compliant in time for the deadline and continue their current distribution strategy they must prepare now.
Over the course of this webinar, Mark Davison, Vice President of International Business at rfxcel will share:
You will walk away with answers to key questions, such as:
To limit the impact on your distribution strategy when this regulation comes into force, use this webinar to kick-start your preparations and understand how these changes will affect you.
About Mark Davison:
Mark Davison is the Vice President of International Business for rfxcel. He is a leading traceability and digital health expert, specializing in the Internet of Things (IoT), traceability, and blockchain solutions. The author of “Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs”, Mark specializes in global health and big data issues that affect key industries such as pharmaceuticals, food/beverage, and fast-moving consumer goods (FMCG). His expertise lies heavily in serialization, supply chain security, patient safety, and government policy. He resides in the United Kingdom.
—
Please fill out the form below to get access to the webinar recording.
THIS WEBINAR ENDED. YOU CAN ACCESS THE RECORDING BELOW.
———
PLEASE CONTACT US BY EMAIL AT rfxwebinars@rfxcel.com OR FILL OUT FORM TO ACCESS WEBINAR RECORDING:
THIS WEBINAR ENDED. YOU CAN ACCESS THE RECORDING BELOW.
———
SEP 26, 2018
Please join rfxcel for a webinar that will provide insight into the upcoming serialisation requirements of the EU FMD and how this relates specifically to Dispensers. In this 45 minute presentation, we will discuss:
1. Overview of the key features of the FMD
2. What the FMD means for Dispensers: Who does what and when are they expected to do so
3. What to think about when selecting a FMD solution provider
4. Stand alone FMD solution versus those integrated with pharmacy software – Pros and Cons
5. How installation and roll-out is performed
About our Speaker:
Mark Davison, based out of the UK, is a leading traceability and digital heath expert as well as the published author of “Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs”. Mark specializes in global health and big data issues such as serialisation, supply chain security, patient safety and government policy. Mark is currently the Senior Operations Director for Europe, at rfxcel, and is looking forward to the opportunity to share his expansive knowledge on this topic.
PLEASE FILL OUT FORM TO ACCESS WEBINAR RECORDING:
© 2024 ANTARES VISION S.p.A. - Via Del Ferro, 16 - 25039 Travagliato - Brescia - ITALY Tel.: +39-030-7283500 / Fax.: +39-030-5109958 / info@antaresvision.com - C/F PIVA: 02890871201 Registro Imprese di Brescia C.C.I.A.A. di Brescia (REA) n. 523277
